ahlam1399
07-09-2015, 10:37 PM
UPDATE 1-FDA panel: Lilly cancer drug has positive risk/benefit profile
WASHINGTON, July 9 (Reuters) - An advisory panel to the U.S.Food and Drug Administration effectively supported approval ofEli Lilly & Co's experimental lung cancer drugnecitumumab on Thursday but...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=VWH2K7632Kw:**iApmyUVpc:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=VWH2K7632Kw:**iApmyUVpc:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=VWH2K7632Kw:**iApmyUVpc:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=VWH2K7632Kw:**iApmyUVpc:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=VWH2K7632Kw:**iApmyUVpc:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/VWH2K7632Kw
WASHINGTON, July 9 (Reuters) - An advisory panel to the U.S.Food and Drug Administration effectively supported approval ofEli Lilly & Co's experimental lung cancer drugnecitumumab on Thursday but...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=VWH2K7632Kw:**iApmyUVpc:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=VWH2K7632Kw:**iApmyUVpc:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=VWH2K7632Kw:**iApmyUVpc:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=VWH2K7632Kw:**iApmyUVpc:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=VWH2K7632Kw:**iApmyUVpc:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/VWH2K7632Kw